NATIONAL JEWISH HEALTH
- Country
- πΊπΈUnited States
- Ownership
- -
- Established
- 1899-01-01
- Employees
- -
- Market Cap
- -
Effect of Omalizumab in the Skin of Food Allergy Patients
- Conditions
- Food AllergyFood Allergy in Children
- Interventions
- First Posted Date
- 2024-10-01
- Last Posted Date
- 2025-05-02
- Lead Sponsor
- National Jewish Health
- Target Recruit Count
- 40
- Registration Number
- NCT06618963
- Locations
- πΊπΈ
National Jewish Health, Denver, Colorado, United States
Enhancing Hypnotic Medication Discontinuation in Primary Care
- Conditions
- InsomniaHypnotic Dependence
- Interventions
- Behavioral: Digital Cognitive Behavioral TherapyBehavioral: Structured Medication Tapering
- First Posted Date
- 2024-05-30
- Last Posted Date
- 2025-06-06
- Lead Sponsor
- National Jewish Health
- Target Recruit Count
- 430
- Registration Number
- NCT06435520
- Locations
- πΊπΈ
National Jewish Health, Denver, Colorado, United States
Nasal Inflammation Following Endotoxin Challenge in Patients With Asthma
- Conditions
- Asthma; EosinophilicAsthma
- Interventions
- Drug: Lipopolysaccharides
- First Posted Date
- 2024-02-21
- Last Posted Date
- 2024-02-21
- Lead Sponsor
- National Jewish Health
- Target Recruit Count
- 60
- Registration Number
- NCT06270576
- Locations
- πΊπΈ
National Jewish Health, Denver, Colorado, United States
Mycobacteriophage Treatment of Non-tuberculosis Mycobacteria
- Conditions
- Cystic FibrosisNontuberculous Mycobacterium InfectionMycobacterium InfectionsMycobacterium; PulmonaryNontuberculous Mycobacterial Lung Disease
- Interventions
- Biological: mycobacteriophage
- First Posted Date
- 2024-02-16
- Last Posted Date
- 2025-05-21
- Lead Sponsor
- National Jewish Health
- Target Recruit Count
- 10
- Registration Number
- NCT06262282
- Locations
- πΊπΈ
University of Alabama, Birmingham, Alabama, United States
πΊπΈChildren's Hospital of Los Angeles, Los Angeles, California, United States
πΊπΈUniversity of California, San Diego, California, United States
Transmission and Acquisition of Nontuberculous Mycobacteria Outbreak Investigation (TrANsMIt)
- Conditions
- Nontuberculous Mycobacterial Pulmonary InfectionMycobacterium InfectionsOutbreak InvestigationHealthcare Associated Infection
- Interventions
- Other: Epidemiologic investigation
- First Posted Date
- 2023-12-04
- Last Posted Date
- 2023-12-12
- Lead Sponsor
- National Jewish Health
- Target Recruit Count
- 100
- Registration Number
- NCT06155747
- Locations
- πΊπΈ
National Jewish Health, Denver, Colorado, United States
Simultaneous quanTification of Elexacaftor/tezAcaftor/Ivacaftor Via Reverse Phase High Performance liquiD chromatographY
- Conditions
- Cystic Fibrosis
- First Posted Date
- 2023-04-20
- Last Posted Date
- 2023-07-24
- Lead Sponsor
- National Jewish Health
- Target Recruit Count
- 100
- Registration Number
- NCT05822102
- Locations
- πΊπΈ
National Jewish Health, Denver, Colorado, United States
πΊπΈSt. Joseph Hospital, Denver, Colorado, United States
Prospective Healthcare-Associated Links in Transmission of Nontuberculous Mycobacteria
- Conditions
- Cystic FibrosisNontuberculous Mycobacterial Pulmonary Infection
- First Posted Date
- 2023-01-17
- Last Posted Date
- 2023-05-08
- Lead Sponsor
- National Jewish Health
- Target Recruit Count
- 100
- Registration Number
- NCT05686837
- Locations
- πΊπΈ
National Jewish Health, Denver, Colorado, United States
COVID-19 Vaccine Response in Chronic Respiratory Conditions
- Conditions
- SARS-CoV Infection
- Interventions
- Biological: COVID-19 vaccine
- First Posted Date
- 2022-04-06
- Last Posted Date
- 2022-04-06
- Lead Sponsor
- National Jewish Health
- Target Recruit Count
- 600
- Registration Number
- NCT05313087
- Locations
- πΊπΈ
National Jewish Health, Denver, Colorado, United States
Reverse HFpEF: Ketogenic Reversal of Heart Failure With Preserved Ejection Fraction Study
- Conditions
- Heart Failure
- Interventions
- Other: Ketogenic Diet
- First Posted Date
- 2021-06-28
- Last Posted Date
- 2024-04-03
- Lead Sponsor
- National Jewish Health
- Target Recruit Count
- 16
- Registration Number
- NCT04942548
- Locations
- πΊπΈ
National Jewish Health and University of Colorado Denver, Denver, Colorado, United States
πΊπΈSaint Joseph Hospital, Denver, Colorado, United States
A Prognostic Transcriptomic Signature for Chronic Hypersensitivity Pneumonitis
- Conditions
- Hypersensitivity Pneumonitis
- First Posted Date
- 2021-04-14
- Last Posted Date
- 2025-05-14
- Lead Sponsor
- National Jewish Health
- Target Recruit Count
- 137
- Registration Number
- NCT04844359
- Locations
- πΊπΈ
University of Arizona, Tucson, Arizona, United States
πΊπΈUniversity of California Davis, Sacramento, California, United States
πΊπΈNational Jewish Health, Denver, Colorado, United States